Kancera AB (KANC)

Stockholm
9.440
-0.390(-3.97%)
  • Volume:
    469,571
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    9.240 - 10.180

KANC Overview

Prev. Close
9.83
Day's Range
9.24-10.18
Revenue
90K
Open
9.91
52 wk Range
9.24-43.3
EPS
-0.78
Volume
469,571
Market Cap
526.49M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
528,343
P/E Ratio
-
Beta
1.88
1-Year Change
-53.08%
Shares Outstanding
55,771,963
Next Earnings Date
31 Aug 2021
What is your sentiment on Kancera AB?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Sell
SummaryStrong BuyBuyStrong SellStrong SellStrong Sell

Kancera AB Company Profile

Kancera AB Company Profile

Employees
8
Market
Sweden

Kancera AB (Publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567 and KAND145 which block the Fractalkine receptor CX3CR1 and thus specific parts of the immune system for treatment of hyperinflammation HDAC6 for the treatment of nerve inflammation and pain; and ROR inhibitors for the treatment of solid tumors and blood cancers. Kancera AB (Publ) was founded in 2010 and is based in Solna, Sweden.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.